Raised Million Without Tech’s: A New Path in Mobility
A mobility startup defies the VC playbook, raising $15 million from private investors. The story highlights disciplin...
Why Index Funds Outperform Active Funds
Active funds frequently lag behind due to fees and manager risk, while index funds provide broad exposure with lower costs and smoother performance.
22,822 articlesOpinion: The Best Memory Stock Isn’t Micron or SanDisk
A fresh take on memory stocks argues that Western Digital could be the best memory stock to own amid AI-driven data c...
XDTE Pays Friday Income with 0DTE Covered Calls Strategy
XDTE uses daily 0DTE call selling to generate income from the S&P 500. This piece explains how the fund works, what i...
CrowdStrike's 4-For-1 Stock Split: What to Know Right Now
CrowdStrike is moving to a 4-for-1 stock split. This guide breaks down what the split does, how it affects you as an ...
Airbnb Carnival Corporation Which Stock Is Better Buy 2026
As 2026 unfolds, investors face a choice between two very different travel giants. One leans on software and hosts to...
JPMorgan Strategist: Financials Could Boom in H2 2026 on Strong Job Growth
A JPMorgan strategist says financial stocks could lead a late-2026 rally if job growth accelerates and broadens beyon...
Palantir Surging in July as Palantir Google Rivalry Heats Up
Palantir surging in July shines a contrast with Google’s cloud-driven growth. Both giants report strong quarters, but...
Stocks That Lose After TSM Earnings: Five Names to Watch
Taiwan Semiconductor's Q2 report is due July 16, shaping AI capex bets. Five stocks stand out as potential winners or...
Drew Brees Wants Brady: WWE Crossover and Personal Finance Strategy
A playful sports feud could become a real money moment. This article breaks down how drew brees wants brady hints at ...
ExxonMobil Stock Surged January: Drivers and Focus
ExxonMobil stock surged January as energy markets moved higher, but the real story runs deeper than a single month. T...
Stock Market Today, Feb.: Inflation Fears and AI Slump
February delivered a chilly stretch for investors as inflation concerns and AI headlines weighed on stock prices. Thi...
UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status